Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”

Yewan Park; Dong Hyun Sinn

doi:10.3350/CMH.2024.0519

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”

Yewan Park
, Dong Hyun Sinn

Department of Internal Medicine

Kyung Hee University

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	718-720
Number of pages	3
Journal	Clinical and molecular hepatology
Volume	30
Issue number	4
DOIs	https://doi.org/10.3350/CMH.2024.0519
State	Published - Oct 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antiviral drug
Chronic hepatitis B
Tumor

Access to Document

10.3350/CMH.2024.0519

Cite this

@article{530da989840f4cadbc27e5d6a5cac55b,

title = "Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”",

keywords = "Antiviral drug, Chronic hepatitis B, Tumor",

author = "Yewan Park and Sinn, \{Dong Hyun\}",

year = "2024",

month = oct,

doi = "10.3350/CMH.2024.0519",

language = "English",

volume = "30",

pages = "718--720",

journal = "Clinical and molecular hepatology",

issn = "2287-285X",

publisher = "Korean Association for the Study of the Liver",

number = "4",

}

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”. / Park, Yewan; Sinn, Dong Hyun.
In: Clinical and molecular hepatology, Vol. 30, No. 4, 10.2024, p. 718-720.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk

T2 - Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”

AU - Park, Yewan

AU - Sinn, Dong Hyun

PY - 2024/10

Y1 - 2024/10

KW - Antiviral drug

KW - Chronic hepatitis B

KW - Tumor

UR - https://www.scopus.com/pages/publications/85208644053

U2 - 10.3350/CMH.2024.0519

DO - 10.3350/CMH.2024.0519

M3 - Editorial

C2 - 38973180

AN - SCOPUS:85208644053

SN - 2287-285X

VL - 30

SP - 718

EP - 720

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

IS - 4

ER -

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than ente-cavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”

UN SDGs

Keywords

Access to Document

Other files and links

Cite this